financetom
Business
financetom
/
Business
/
Westinghouse says KHNP not authorised for Czech nuclear tender
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Westinghouse says KHNP not authorised for Czech nuclear tender
Jul 17, 2024 7:22 AM

LONDON, July 17 (Reuters) - U.S. company Westinghouse

said South Korea's KHNP is not authorised to use its reactor

technology for a tender to build Czech nuclear projects without

its agreement.

The Czech government on Wednesday picked Korea Hydro &

Nuclear Power (KHNP) over rival French bidder EDF to build two

nuclear power units after a lengthy tender process.

Westinghouse said KHNP had failed to comply with U.S. export

rules that require authorisation from the U.S. government before

its technology can be shared.

"Westinghouse reserves its rights to challenge this in front

of the relevant national and international jurisdictions," it

said in an emailed statement.

KHNP did not provide immediate comment.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TotalEnergies posts drop in fourth-quarter profit on weak oil demand
TotalEnergies posts drop in fourth-quarter profit on weak oil demand
Feb 4, 2025
PARIS (Reuters) - French oil major TotalEnergies reported a 15% drop in fourth-quarter earnings on Wednesday, closing out a year marked by low oil prices and weak fuel demand that were partially offset by higher electricity sales and liquefied natural gas trading. Adjusted net income for the final three months of 2024 was $4.4 billion, down from $5.2 billion a...
Lockmaker Assa Abloy posts higher Q4 operating profit
Lockmaker Assa Abloy posts higher Q4 operating profit
Feb 4, 2025
Feb 5 (Reuters) - Sweden's Assa Abloy, the world's biggest lockmaker, reported a 14% increase in its fourth quarter operating profit on Wednesday, citing a strong operating leverage driven by continued price/cost tailwind and strong operational execution. ...
GSK beats Q4 earnings estimates, lifts 2031 sales target
GSK beats Q4 earnings estimates, lifts 2031 sales target
Feb 4, 2025
Feb 5 (Reuters) - GSK forecast sales in 2025 to grow 3%-5% and reported better-than-expected fourth-quarter earnings, as strength in its HIV and oncology portfolio offset weakness in its vaccines division. The British drugmaker also lifted its 2031 sales forecast to more than 40 billion pounds ($49.88 billion), from 38 billion pounds it targeted earlier, citing progress on its late-stage...
GSK's fourth-quarter earnings beat expectations
GSK's fourth-quarter earnings beat expectations
Feb 4, 2025
Feb 5 (Reuters) - GSK forecast sales in 2025 to grow between 3% and 5%, and reported a better-than-expected fourth quarter earnings, as strength in its HIV and oncology portfolio offset weakness in its vaccines division. The company reported core earnings per share of 23.2 pence on sales of 8.12 billion pounds ($10.13 billion) for the quarter ended Dec. 31,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved